Saturday 17 October 2026
Export UHS’s income statement to Excel — free account
Universal Health Services, Inc.
UHS Healthcare Medical Care Facilities
Universal Health Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $17.4 billion, up 9.71% from fiscal 2024. In the quarter to June 2026, revenue grew 8.27%, EPS grew 9.47%, free cash flow fell 23.8% and total debt rose 5.87%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten.
185.10
2.26
−1.21%
Follow UHS
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
19.77% | 21.14% | 21.12% | 20.81% | |
Piotroski F-Score |
8 | 8 | 8 | 8 | |
| 9.26% | 9.93% | 9.95% | 9.87% | ||
ROIC |
10.32% | 10.43% | 10.53% | 10.46% | |
Return on Tangible Assets |
19.45% | 20.75% | 20.78% | 20.28% | |
Average Days of Receivables |
55.53 | 54.70 | 56.42 | 56.44 | |
Free Cash Flow per Share |
15.08 | 13.36 | 14.94 | 14.17 | |
Free Cash Flow |
949.59 | 849.25 | 912.69 | 845.40 | |
Capital Expenditures |
(998.55) | (1,015.15) | (993.28) | (954.90) | |
| Other line items | |||||
Cash ROIC |
7.89% | 6.94% | 7.39% | 6.72% | |
Accounts Receivable Turnover |
7.08 | 7.27 | 6.89 | 7.10 | |
Accounts Payable Turnover |
0.78 | 1.09 | 0.76 | 0.73 | |
Inventory Turnover |
7.35 | 7.32 | 7.46 | 7.39 | |
Average Days of Payables |
518.43 | 531.61 | 511.13 | 530.29 | |
Days of Inventory on Hand |
50.38 | 51.07 | 49.76 | 50.64 | |
Tax Rate |
(0.23) | (0.23) | (0.23) | (0.24) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
46.76% | 46.56% | 46.29% | 46.08% | |
Share Based Compensation of Revenue |
0.57% | 0.55% | 0.54% | 0.53% | |
Interest Coverage |
12.69 | 12.78 | 13.33 | 13.05 | |
Operating CF/Net income |
1.42 | 1.25 | 1.25 | 1.18 | |
Depreciation/Fixed assets |
0.09 | 0.09 | 0.09 | 0.09 | |
Capex/Depreciation |
(1.66) | (1.64) | (1.59) | (1.49) | |
Revenue per Share |
269.83 | 273.11 | 290.81 | 303.64 | |
Operating CF per Share |
30.94 | 29.32 | 31.21 | 30.18 | |
Capex per Share |
(15.86) | (15.97) | (16.26) | (16.01) | |
Capex to Sales |
0.06 | 0.06 | 0.06 | 0.05 |
Columns are period end dates